IN BRIEF: Mercia Sells Stake In Native Antigen For Up To GBP18 Million

Thu, 09th Jul 2020 18:07

Mercia Asset Management PLC - regionally-focused specialist asset manager - Sells stake in Native Antigen Co Ltd to LGC, a global leader in the life sciences tools sector, for a total cash consideration of up to GBP18.0 million.

Mercia held a 29% fully diluted direct holding in NAC and will receive initial cash proceeds of GBP4.8million, with up to a further GBP0.4million receivable upon finalisation of customary closing working capital calculations.

Current stock price: 19.65 pence

Year-to-date change: down 24%

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Related Shares

More News

10 Apr 2024 12:00

Mercia Asset Management reports record fund inflows

(Sharecast News) - Mercia Asset Management released its trading summary for the financial year ended 31 March on Wednesday, with organic fund inflows ...

10 Apr 2024 11:20

Mercia Asset Management hails portfolio's annual performance

(Alliance News) - Mercia Asset Management PLC on Wednesday said it had achieved a record level of organic fund inflows in its latest financial year in...

22 Mar 2024 14:07

DIRECTOR DEALINGS: Hollywood Bowl COO Lewis sells 180,000 shares

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately...

21 Mar 2024 19:05

EARNINGS AND TRADING: Getech confident; Aukett Swanke makes buy

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately report...

21 Mar 2024 13:38

Mercia Asset Management secures two new BBB mandates

(Sharecast News) - Mercia Asset Management announced an expanded role in bolstering regional business growth on Thursday, with the acquisition of two ...